Oxidative stress and vascular function: implications for pharmacologic treatments

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Pharmacology

Background:

• Reactive oxygen species (ROS) production causes oxidative stress, a key factor in endothelial dysfunction and cardiovascular diseases.
• Vascular enzymes like NADPH oxidases, xanthine oxidase, and uncoupled endothelial nitric oxide synthase are primary sources of ROS.
• The efficacy of pharmacological interventions against excessive vascular ROS remains an important question.

Purpose of the Study:

• To investigate the potential of pharmacological approaches to counteract excessive ROS production in the vasculature.
• To explore the antioxidant capabilities of existing cardiovascular drugs and novel compounds.
• To assess the role of food-derived compounds in mitigating oxidative stress and maintaining vascular health.

Main Methods:

• Review of existing literature on ROS production in cardiovascular pathology.
• Analysis of known antioxidant properties of registered cardiovascular drugs.
• Examination of novel compounds targeting NADPH oxidases.
• Evaluation of studies on food-derived antioxidants and their vascular effects.

Main Results:

• Existing cardiovascular drugs can possess direct or indirect antioxidant effects, protecting against ROS damage.
• New compounds specifically designed to target NADPH oxidases have been developed.
• Food-derived compounds demonstrate effectiveness in inhibiting oxidative stress and preserving vascular function.

Conclusions:

• Pharmacological strategies, including existing drugs and novel agents, hold potential for managing vascular oxidative stress.
• Dietary compounds represent a promising avenue for antioxidant therapy in cardiovascular health.
• Targeting ROS production is a viable strategy for preventing endothelial dysfunction and cardiovascular disease.